24 Recruiting Esophageal Squamous Cell Carcinoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by Study Phase
Top Interventions for Esophageal Squamous Cell Carcinoma
Top Recruiting Esophageal Squamous Cell Carcinoma Studies
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy
📍 Florida Cancer Specialists - Fort Myers (Broadway) — Fort Myers, Florida
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Study of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCC
📍 Research Site — Atlanta, Georgia
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
📍 UPMC Hillman Cancer Center ( Site 1904) — Pittsburgh, Pennsylvania
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
📍 University of Arizona Cancer Center-University of Arizona Cancer Center ( Site 4927) — Tucson, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer
📍 McGill University Health Centre — Montreal, Quebec
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
📍 Sarah Cannon Research Institute at HealthONE — Denver, Colorado
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
📍 Mayo Clinic Hospital — Phoenix, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
📍 Research Site — Scottsdale, Arizona
View Study & Checklist ➔